|
| |
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online September 23, 2003
Review Article |
Antimalarial drug discovery: old and new approaches
Department of Medicine, University of California, San Francisco, CA 94143, USA
(e-mail: rosnthl{at}itsa.ucsf.edu)
Accepted 2 July 2003
New drugs against malaria are greatly needed. Many approaches to antimalarial drug discovery are available. These approaches must take into account specific concerns, in particular the requirement for very inexpensive and simple to use new therapies and the need to limit the cost of drug discovery. Among important efforts that are currently ongoing are the optimization of therapy with available drugs, including the use of combination therapy, the development of analogs of existing agents, the discovery of natural products, the use of compounds that were originally developed against other diseases, the evaluation of drug resistance reversers, and the consideration of new chemotherapeutic targets. The last category benefits from recent advances in malaria research technologies and genomics and is most likely to identify new classes of drugs. A number of new antimalarial therapies will likely be needed over the coming years, so it is important to pursue multiple strategies for drug discovery.
Key words: malaria, Plasmodium falciparum, drugs, chemotherapy, drug discovery, resistance
Related articles in JEB:
This article has been cited by other articles:
|
|
 |
|
  L. Cui, J. Miao, and L. Cui Cytotoxic Effect of Curcumin on Malaria Parasite Plasmodium falciparum: Inhibition of Histone Acetylation and Generation of Reactive Oxygen Species Antimicrob. Agents Chemother., February 1, 2007; 51(2): 488 - 494. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Stack, J. Lowther, E. Cunningham, S. Donnelly, D. L. Gardiner, K. R. Trenholme, T. S. Skinner-Adams, F. Teuscher, J. Grembecka, A. Mucha, et al. Characterization of the Plasmodium falciparum M17 Leucyl Aminopeptidase: A PROTEASE INVOLVED IN AMINO ACID REGULATION WITH POTENTIAL FOR ANTIMALARIAL DRUG DEVELOPMENT J. Biol. Chem., January 19, 2007; 282(3): 2069 - 2080. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. M. Kim, M. H. Lee, T. G. Piao, J. W. Lee, J. H. Kim, S. Lee, K. M. Choi, J. H. Jiang, T. U. Kim, and H. Park Prodomain Processing of Recombinant Plasmepsin II and IV, the Aspartic Proteases of Plasmodium falciparum, Is Auto- and Trans-Catalytic J. Biochem., February 1, 2006; 139(2): 189 - 195. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Gardiner, K. R. Trenholme, T. S. Skinner-Adams, C. M. Stack, and J. P. Dalton Overexpression of Leucyl Aminopeptidase in Plasmodium falciparum Parasites: TARGET FOR THE ANTIMALARIAL ACTIVITY OF BESTATIN J. Biol. Chem., January 20, 2006; 281(3): 1741 - 1745. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. C. Pandey, S. X. Wang, P. S. Sijwali, A. L. Lau, J. H. McKerrow, and P. J. Rosenthal The Plasmodium falciparum cysteine protease falcipain-2 captures its substrate, hemoglobin, via a unique motif PNAS, June 28, 2005; 102(26): 9138 - 9143. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. D. Vernick and A. P. Waters Genomics and Malaria Control N. Engl. J. Med., October 28, 2004; 351(18): 1901 - 1904. [Full Text] [PDF]
|
|
|
|
 |
|
 P. L. Olliaro and W. R. J. Taylor Antimalarial compounds: from bench to bedside J. Exp. Biol., November 1, 2003; 206(21): 3753 - 3759. [Abstract] [Full Text] [PDF]
|
|
